Application 087355
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NITROGLYCERIN | NITROGLYCERIN | OINTMENT;TRANSDERMAL | 2% | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A087355-001 | NITROGLYCERIN | NITROGLYCERIN | 2% | OINTMENT / TRANSDERMAL | AB | RLD, RS | 1988-07-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A087355-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A087355-001 | NITROGLYCERIN | 2% | OINTMENT / TRANSDERMAL | AB | RLD, RS | 1988-07-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A087355-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NITRO-BID | NITROGLYCERIN | Savage Laboratories a division of Fougera Pharmaceuticals, LLC | e464e9bb-48e8-4b9f-9fff-e220cfbac0c5 | 2026-01-28 | Warnings, Adverse reactions | 087355 ANDA087355 0281-0326 |
| NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | 7da79fdf-0969-1ddd-e053-2991aa0a3ec4 | 2022-12-09 | Warnings, Adverse reactions | 087355 ANDA087355 51662-1340 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0326 | NITRO-BID | Nitroglycerin | E. FOUGERA & CO., A division of Nycomed US Inc. | ANDA | Current |
| 0281-0326 | NITRO-BID | Nitroglycerin | Savage Laboratories a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0281-0326 | NITRO-BID | Nitroglycerin | Savage Laboratories a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0281-0326 | NITRO-BID | Nitroglycerin | Savage Laboratories a div | ANDA | Current |
| 0281-0326 | NITRO-BID | Nitroglycerin | Savage Laboratories a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0281-0326 | NITRO-BID | Nitroglycerin | Savage Laboratories a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 51662-1340 | NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1340 | NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1340 | NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1340 | NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |